Lower Reimbursement For Accelerated Approval Drugs May Get Push From ICER

 
• By Sarah Karlin-Smith
dollar sign with down arrow
ICER may soon suggest accelerated approval drugs start at low price points. • Source: Shutterstock

More from Pricing Debate

More from Market Access